New radiation therapy trial for chordoma patients open at MGH
Dr. Tom DeLaney of Massachusetts General Hospital is leading a new Phase II study that will utilize the newest technology … Continue reading
Dr. Tom DeLaney of Massachusetts General Hospital is leading a new Phase II study that will utilize the newest technology … Continue reading
Over the past several years, interest in chordoma has grown and numerous new investigators have ventured into chordoma research. During … Continue reading
Chordoma Foundation Executive Director, Josh Sommer, has been named by Forbes to its list of “30 Under 30,” 30 individuals … Continue reading
The University of Pittsburgh and Dignity Health’s Barrow Neurological Institute at St. Joseph’s Hospital and Medical Center are the latest … Continue reading
In the year following the Third International Chordoma Research Workshop, participants formed 30 new collaborations (thick lines) and 174 new … Continue reading
The newest member of the Chordoma Foundation’s growing team, Patty Cogswell brings over 25 years of cancer research experience to … Continue reading
Scientists working on the Chordoma Genome Project have identified a genetic variant (a SNP) that causes a five-fold increase in … Continue reading
Foundation-funded research yields major discovery that could open door to new therapies For the first time ever, scientists have identified … Continue reading
Researchers at Johns Hopkins Hospital are testing a new cancer treatment that uses bacteria to kill tumors, and chordoma may … Continue reading
One thing Alison Laird delighted in most during her eight-year battle with chordoma was proving her doctors wrong. A woman … Continue reading